comparemela.com

Latest Breaking News On - Potent nurr - Page 1 : comparemela.com

Immunic, Inc Reports Second Quarter 2023 Financial Results and Provides Corporate Update

– Preclinical Data Published in the Journal of Medicinal Chemistry Identifies Vidofludimus Calcium as a Potent Nurr1 Activator, Reinforcing Neuroprotective.

Paula schwartzDaniel vittJessica breuEdna kaplanVincent ossipowRichard rudickDevelopment rd expensesRx communications groupExchange commissionPrnewswire immunic incImmunic incPreclinical data publishedPotent nurrReinforcing neuroprotective potentialMultiple sclerosisPositive results from phase

Potential MS therapy vidofludimus calcium triggers Nurr1 protein | Multiple Sclerosis News Today

Multiple sclerosis treatment candidate vidofludimus calcium was found to activate the neuroprotective protein Nurr1 in preclinical studies.

Daniel merkDaniel vittHella kohlhofEuropean unionImmunic therapeuticsPotent nurrVivo applicationsLudwig maximilians university munich

EQS-News: Immunic Announces That Vidofludimus Calcium Acts as Potent Nurr1 Activator, Reinforcing Neuroprotective Potential in Multiple Sclerosis

Issuer: Immunic, Inc. / Key word(s): Scientific publication Immunic Announces That Vidofludimus Calcium Acts as Potent Nurr1 Activator, Reinforcing Neuroprotective Potential in Multiple Sclerosis 17.05.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. I.

United statesDaniel merkDaniel vittJessica breuEdna kaplanHella kohlhofPaula schwartzEuropean unionDepartment of pharmacyImmunic incDistribution servicesRx communications groupExchange commissionAnnounces that vidofludimus calcium actsPotent nurrReinforcing neuroprotective potential

Immunic Announces That Vidofludimus Calcium Acts as Potent Nurr1 Activator, Reinforcing Neuroprotective Potential in Multiple Sclerosis

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.

United statesJessica breuDaniel merkPaula schwartzHella kohlhofEdna kaplanDaniel vittExchange commissionPrnewswire immunic incRx communications groupEuropean unionDepartment of pharmacyImmunic incPreclinical data publishedPeer reviewed journalPotent nurr

EQS-News: Immunic, Inc : Immunic Announces That Vidofludimus Calcium Acts as Potent Nurr1 Activator, Reinforcing Neuroprotective Potential in Multiple Sclerosis

Issuer: Immunic, Inc. / Key word(s): Scientific publication Immunic Announces That Vidofludimus Calcium Acts as Potent Nurr1 Activator, Reinforcing Neuroprotective Potential in Multiple Sclerosis

United statesGewinn nurDaniel vittPaula schwartzJessica breuHella kohlhofDaniel merkEdna kaplanRx communications groupDistribution servicesExchange commissionDepartment of pharmacyImmunic incEuropean unionAnnounces that vidofludimus calcium actsPotent nurr

vimarsana © 2020. All Rights Reserved.